The transaction should be complete in the second quarter of 2013.
Baxano is in the process of developing the iO-Tome system, a precision facetectomy instrument. Trans1 is looking to expand its focus on minimally invasive lumbar spine treatments and improve its financial profile, according to the release.
More Articles on Devices:
Spine Device Manufacturer NuVasive Posts $2.7M 4Q Loss
ArthroCare SpeedLock Hip Implant Cleared by FDA
5 Orthopedic & Spine Device Company Expansions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.